Ignite Creation Date:
2024-05-06 @ 7:19 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02511184
Status:
TERMINATED
Last Update Posted:
2019-07-01
First Post:
2015-07-22
Brief Title:
Crizotinib Plus Pembrolizumab In Alk-Positive Advanced Non Small Cell Lung Cancer Patients
Sponsor:
Pfizer
Organization:
Pfizer